Related references
Note: Only part of the references are listed.Body image dissatisfaction in pregnant and non-pregnant females is strongly predicted by immune activation and mucosa-derived activation of the tryptophan catabolite (TRYCAT) pathway
Chutima Roomruangwong et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2018)
Deficit Schizophrenia Is Characterized by Defects in IgM-Mediated Responses to Tryptophan Catabolites (TRYCATs): a Paradigm Shift Towards Defects in Natural Self-Regulatory Immune Responses Coupled with Mucosa-Derived TRYCAT Pathway Activation
Buranee Kanchanatawan et al.
MOLECULAR NEUROBIOLOGY (2018)
Reversal of schizophrenia-like symptoms and immune alterations in mice by immunomodulatory drugs
Tatiane da Silva Araujo et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2017)
Neurocognitive impairment in the deficit subtype of schizophrenia
Gagan Fervaha et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2016)
The Many Neuroprogressive Actions of Tryptophan Catabolites (TRYCATs) that may be Associated with the Pathophysiology of Neuro-Immune Disorders
Gerwyn Morris et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression
D. R. Goldsmith et al.
MOLECULAR PSYCHIATRY (2016)
A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis
Justin Davis et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2016)
Kynurenine and Tryptophan Levels in Patients With Schizophrenia and Elevated Antigliadin Immunoglobulin G Antibodies
Olaoluwa Okusaga et al.
PSYCHOSOMATIC MEDICINE (2016)
Anthranilic acids from isatin: an efficient, versatile and environmentally friendly method
Gabriel F. Rio et al.
ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS (2015)
Oxidative stress in drug naive first episode psychosis and antioxidant effects of risperidone
Cristiano Noto et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2015)
Effects of depression on the cytokine profile in drug naive first-episode psychosis
Cristiano Noto et al.
SCHIZOPHRENIA RESEARCH (2015)
Gastroenterology Issues in Schizophrenia: Why the Gut Matters
Emily G. Severance et al.
CURRENT PSYCHIATRY REPORTS (2015)
Xanthurenic Acid Activates mGlu2/3 Metabotropic Glutamate Receptors and is a Potential Trait Marker for Schizophrenia
Francesco Fazio et al.
SCIENTIFIC REPORTS (2015)
Deficit schizophrenia: an update
BRIAN KIRKPATRICK et al.
World Psychiatry (2015)
The gut-brain axis: The role of melatonin in linking psychiatric, inflammatory and neurodegenerative conditions
George Anderson et al.
ADVANCES IN INTEGRATIVE MEDICINE (2015)
Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollaries
Justin Davis et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2014)
Cytokine function in medication-naive first episode psychosis: A systematic review and meta-analysis
Rachel Upthegrove et al.
SCHIZOPHRENIA RESEARCH (2014)
Modulation of Hippocampal Synaptic Transmission by the Kynurenine Pathway Member Xanthurenic Acid and Other VGLUT Inhibitors
S. A. Neale et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Schizophrenia is primed for an increased expression of depression through activation of immuno-inflammatory, oxidative and nitrosative stress, and tryptophan catabolite pathways
George Anderson et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
Schizophrenia: Linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression
George Anderson et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways
Michael Maes et al.
BMC MEDICINE (2012)
Xanthurenic Acid Binds to Neuronal G-Protein-Coupled Receptors That Secondarily Activate Cationic Channels in the Cell Line NCB-20
Omar Taleb et al.
PLOS ONE (2012)
Increased Levels of Kynurenine and Kynurenic Acid in the CSF of Patients With Schizophrenia
Klas R. Linderholm et al.
SCHIZOPHRENIA BULLETIN (2012)
On the antioxidant properties of kynurenic acid: Free radical scavenging activity and inhibition of oxidative stress
R. Lugo-Huitron et al.
NEUROTOXICOLOGY AND TERATOLOGY (2011)
The new '5-HT' hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression
M. Maes et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Decreased plasma tryptophan and tryptophan/large neutral amino acid ratio in patients with neuroleptic-resistant schizophrenia: Relationship to plasma cortisol concentration
Myung Lee et al.
PSYCHIATRY RESEARCH (2011)
Acute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantamine
Kathleen S. Alexander et al.
PSYCHOPHARMACOLOGY (2011)
Impaired Kynurenine Pathway Metabolism in The Prefrontal Cortex of Individuals With Schizophrenia
Korrapati V. Sathyasaikumar et al.
SCHIZOPHRENIA BULLETIN (2011)
Aging-associated increase in indoleamine 2,3-dioxygenase (IDO) activity appears to be unrelated to the transcription of the IDO1 or IDO2 genes in peripheral blood mononuclear cells
Saara Marttila et al.
Immunity & Ageing (2011)
On the Biological Importance of the 3-hydroxyanthranilic Acid: Anthranilic Acid Ratio
L. Gail Darlington et al.
INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH (2010)
Alzheimer's and Seizures: Interleukin-18, Indoleamine 2,3-Dioxygenase and Quinolinic Acid
G. Anderson et al.
INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH (2010)
Indoleamine 2,3-Dioxygenase in Intestinal Immunity and Inflammation
Bobby J. Cherayil
INFLAMMATORY BOWEL DISEASES (2009)
Constitutive Expression of IDO by Dendritic Cells of Mesenteric Lymph Nodes: Functional Involvement of the CTLA-4/B7 and CCL22/CCR4 Interactions
Toshiharu Onodera et al.
JOURNAL OF IMMUNOLOGY (2009)
Kynurenine pathway in psychosis: evidence of increased tryptophan degradation
S. Barry et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2009)
SPECIFIC INHIBITION OF KYNURENATE SYNTHESIS ENHANCES EXTRACELLULAR DOPAMINE LEVELS IN THE RODENT STRIATUM
L. Amori et al.
NEUROSCIENCE (2009)
Relationship of cognition and psychopathology to functional impairment in schizophrenia
Somaia Mohamed et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Xanthurenic acid distribution, transport, accumulation and release in the rat brain
Serge Gobaille et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Characterization of the kynurenine pathway in human neurons
Gilles J. Guillemin et al.
JOURNAL OF NEUROSCIENCE (2007)
Nanomolar concentrations of kynurenic acid reduce extracellular dopamine levels in the striatum
A Rassoulpour et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: A longitudinal first-episode study with 7-year follow-up
P Milev et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia
CL Miller et al.
NEUROBIOLOGY OF DISEASE (2004)
Biochemical and phenotypic abnormalities in kynurenine aminotransferase II-deficient mice
P Yu et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Picolinic acids as inhibitors of dopamine β-monooxygenase:: QSAR and putative binding site
S Dove
ARCHIV DER PHARMAZIE (2004)
Deficit versus negative syndrome in schizophrenia: Prediction of attentional impairment
AS Cohen et al.
SCHIZOPHRENIA BULLETIN (2004)
Effects of systemic and central nervous system localized inflammation on the contributions of metabolic precursors to the L-kynurenine and quinolinic acid pools in brain
T Kita et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Enhanced neuronal damage by co-administration of quinolinic acid and free radicals, and protection by adenosine A(2A) receptor antagonists
WMH Behan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Increased cortical kynurenate content in schizophrenia
R Schwarcz et al.
BIOLOGICAL PSYCHIATRY (2001)
The tryptophan catabolite picolinic acid selectively induces the chemokines macrophage inflammatory protein-1α and-1β in macrophages
MC Bosco et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
